Company Delta-Fly Pharma, Inc.

4598

JP3549370009

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-02 EDT			5-day change	1st Jan Change
739 ^JPY	+1.23%		-7.74%	-27.19%

04-08	Delta-Fly Pharma Inc. Receives Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 Combined with Venetoclax	CI
03-11	Delta-Fly Pharma Inc. Announces FDA Submission of the Protocol of the Phase I/II Study of DFP-10917 Combined with Venetoclax in the AML Patients Treated by VTX in the AML	CI

Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is refractory or recurrent acute myelogenous leukemia, anticancer drug candidate compound DFP-14323 whose target disease is lung cancer, anti-cancer drug candidate compound DFP-11207 whose target disease is solid cancer, anticancer drug candidate compound DFP-14927 whose target disease is solid cancer or blood cancer, anticancer drug candidate compound DFP-10825 whose target disease is peritoneal dissemination metastatic cancer.

Number of employees: 11

Managers	Title	Age	Since
Kiyoshi Eshima FOU	Founder	74	10-12-05
Kenichi Kurotaki ADM	Chief Administrative Officer	58	19-08-31
Kenzo Iizuka CTO	Chief Tech/Sci/R&D Officer	61	12-03-31
Yasuo Matsueda BRD	Director/Board Member	63	16-07-31
Kimura Masaya AUD	Comptroller/Controller/Auditor	68	11-09-30

Members of the board	Title	Age	Since
Kiyoshi Eshima FOU	Founder	74	10-12-05
Kenzo Iizuka CTO	Chief Tech/Sci/R&D Officer	61	12-03-31
Yasuo Matsueda BRD	Director/Board Member	63	16-07-31
Bando Yoshihiko BRD	Director/Board Member	75	16-05-31
Takeshi Shinohara BRD	Director/Board Member	51	17-05-31
Sachio Kishii BRD	Director/Board Member	45	17-05-31
Kinichiro Kominami BRD	Director/Board Member	57	18-05-31
Kenichi Kurotaki ADM	Chief Administrative Officer	58	19-08-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	8,229,900	6,482,002 ( 78.76 %)	198 ( 0.002406 %)	78.76 %

Name	Equities	%	Valuation
Kiyoshi Eshima 8.287 %	682,000	8.287 %	4 M ¥
NIPPON CHEMIPHAR CO., LTD. 5.228 %	430,300	5.228 %	2 M ¥
SANYO CHEMICAL INDUSTRIES,LTD. 1.823 %	150,000	1.823 %	834 518 ¥
Kenzo Iizuka 1.033 %	85,000	1.033 %	472 893 ¥
Masakazu Fukushima 0.8384 %	69,000	0.8384 %	383 878 ¥
THE AWA BANK, LTD. 0.3645 %	30,000	0.3645 %	166 904 ¥
Kimura Masaya 0.1823 %	15,000	0.1823 %	83 452 ¥
DELTA-FLY PHARMA, INC. 0.001215 %	100	0.001215 %	556 ¥

Name	Equities	%	Valuation
DELTA-FLY PHARMA, INC. 0.00%	100	0.00%	556 $

Delta-Fly Pharma, Inc.

37-5 Miyajima Nishikino Kawauchu-cho

771-0116, Tokushima

http://www.delta-flypharma.co.jp

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
DELTA-FLY PHARMA, INC.	-27.19%	39.54M
ELI LILLY AND COMPANY	+26.92%	681B
NOVO NORDISK A/S	+21.85%	556B
JOHNSON & JOHNSON	-5.01%	361B
MERCK & CO., INC.	+17.13%	325B
ABBVIE INC.	+5.23%	285B
ASTRAZENECA PLC	+13.68%	235B
NOVARTIS AG	+3.65%	199B
ROCHE HOLDING AG	-11.12%	189B
PFIZER, INC.	-4.17%	157B

Other Pharmaceuticals